Related Experiment Video

Updated: Jul 15, 2026

Generation and Genetic Manipulation of Human Cervical Organoids
10:29

Generation and Genetic Manipulation of Human Cervical Organoids

Published on: March 10, 2026

The development and future of oligonucleotide-based therapies for cervical cancer

Wenyi Gu1, Lisa N Putral, Aaron Irving

  • 1University of Queensland, Diamantina Institute for Cancer, Immunology and Molecular Medicine, Cancer Biology Programme, Brisbane, QLD 4072, Australia.

Current Opinion in Molecular Therapeutics
|April 27, 2007
PubMed

Insights

Gene-specific therapies targeting human papillomavirus (HPV) oncogenes show promise for cervical cancer. Small interfering RNA (siRNA) offers advantages, but delivery and specificity challenges remain for clinical use.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Cervical cancer presents a unique model for gene-specific therapy due to the role of HPV oncogenes E6 and E7.
  • Oligonucleotide-based therapies, including antisense oligonucleotides, ribozymes, and small interfering RNA (siRNA), have been explored for cancer treatment.

Purpose of the Study:

  • To review the development and application of oligonucleotide-based therapies for cervical cancer.
  • To evaluate the potential of siRNA as a therapeutic agent for cervical cancer, comparing it to older technologies.

Main Methods:

  • Review of existing literature on antisense oligonucleotides, ribozymes, and siRNA therapies.
  • Analysis of in vitro studies investigating siRNA efficacy against cervical cancer cells.

Main Results:

  • In vitro studies demonstrate promising results for siRNA in targeting cervical cancer cells.
  • siRNA technology offers advantages over antisense and ribozyme approaches.

Conclusions:

  • While siRNA shows potential for cervical cancer treatment, challenges in target selection, specificity, and delivery must be addressed.
  • Overcoming current obstacles could lead to potent new therapies for cervical cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...